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Abstract 
The tolerance and antiplasmodial activity of methanolic root extract of R. longipedicellata in P. berghei 
infected mice was investigated. Extract was administered to mice at 1500mg/kg for 30days and liver and 
kidney parameters were analysed. Mice were infected with P. berghei and administered the extract and 
reference drugs 2hrs and 5days post-infection for suppressive and therapeutic activities respectively. At 
1500mg/kg dose, R. longipedicellata extract exhibited a significant decrease (p ≤0.05) in ALP, GOT, GPT 
and Creatinine. Bilirubin showed no significant change while PCV was increased (p ≤0.05). Inhibition in 
suppressive activity at 50 and 100mg/kg doses of the extracts were 86.8% and 65.43% while artesunate 
(120mg/kg) and chloroquine (8mg/kg) were 100%.  Clearance rate in therapeutic activity for 50 and 
100mg/kg dose of R. longipedicellata extract were 36.73% and 64.60%, lower than chloroquine (80.85%) 
and artesunate (100%). Longest survival period was observed in 50mg/kg suppressive group than all the 
groups treated with R. longipedicellata methanolic root extract. This study suggests that the methanolic 
root extract of R. longipedicellata is well tolerated and possesses antiplasmodial activity in mice infected 
with P.berghei. 
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INTRODUCTION 
 
Herbal medicines still remains the major source 
of health care delivery in Africa. Establishing 
the safety and efficacy of these herbal medicines 
pose a major challenge to the African medical 
scientist.  
 
In Africa, the malaria situation has deteriorated 
during the past decades
1
 for several reasons, one 
of which is the emergence of drug resistance 
strain of plasmodium. This has compromised 
malaria therapy and has led to the search for new 
lead compounds in medicinal plants used in folk 
medicine for the treatment of the disease. This  
is predicated on the fact that studies have shown 
a high correlation between pharmacological 
activity/clinical use of plant isolates and their 
established use as herbal medicine
2,3,4
. Although 
aqueous decoction is the most common method 
of ethno medical preparation, alcoholic 
extraction is also widely used especially in the 
Delta region of Nigeria. The roots or stem or 
sometimes leaves of these plants are cut in bits 
and put into bottles into which locally distilled 
ethanol is added. This preparation is dispensed 
in a shot glass every morning to prevent malaria. 
In Africa, traditional healing methods with herbs 
take a holistic approach to health care. The use 
and action of the whole plant is preferred to 
isolated constituents of the plant. Some workers 
report that this approach produces synergy
5,6
. 
However, most of these plants have not been 
investigated for safety or efficacy. Therefore the 
therapeutic values of these plants need to be 
supported by scientific data of their safety and 
efficacy. 
 
Thus, the objective of this study is to evaluate 
the tolerance level and the antiplasmodial 
activity of methanolic root extract of 
R.longipedicellata Gilg (Capparidaceae) in 
Plasmodium berghei infection in mice. R 
longipedicellata, a climbing shrub is used as a 
tonic and antimalaria in herbal medicine in 
Nigeria. 
 
MATERIALS AND METHOD 
 
Chemicals and Solvents  
All solvents used for extraction were of 
analytical grade and supplied by Sigma-Aldrich 
Chemical Company Ltd. Germany. Bioassay of 
biochemical parameters was carried out with 
assay kit supplied by Randox Industries Ltd. 
UK. 
 
Plant Material 
The root of R.longipedicellata was collected by 
Mr. Felix Isang of Forestry Research Institute 
(FRIN) Ibadan. Mr.TK Odewo of the same 
Institute authenticated the plant. Voucher 
specimen of the plant with No FHI 106997 was 
deposited at the FRIN Herbarium. 
 
Extraction 
100g of air-dried crushed plant material (root) 
were extracted with 500ml MeOH-H20 (8:2 v/v) 
at room temperature under reflux for 8 hours (by 
Soxhlet method). The extract solution was 
filtered, concentrated by air-drying on the 
bench and freeze-dried. 
 
Phytochemical Analysis 
Phytochemical analysis of R.longipedicellata 
was performed according to the method of 
Sofowora
7
. The presence of alkaloids, 
glycosides, reducing sugars, tannins, saponins 
and flavonoids was determined. 
 
Animal Source  
50 adult Swiss albino mice weighing between 
20–25gm were purchased from the animal center 
of Federal Vaccine Production Laboratories. 
Yaba, Lagos. They were sorted into 5 groups of 
5 mice each, housed in standard mouse cages, 
fed with livestock feed and water ad libitum. 
 
Acute Toxicity 
Determination of the dose of root extract of R. 
longipedicellata that would kill 50% of the 
animal population (LD50) was undertaken 
according to the method of Litchfield and 
Wilcox as described by Aji et al.
8
.  
 
Twenty-five male mice sorted into five groups 
of 5 mice each were used for the experiment. 
They were fasted for 12 hours but were allowed 
water freely. Doses of 20g/kg, 15g/kg 10g/kg, 
5g/kg and 2.5g/kg was administered orally with 
the aid of oral cannular and the animals were 
observed for 24hrs. Mortality in each group was 
recorded; the LD50 was calculated using the plot 
of percentage mortality against the log of dose.  
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Tolerance Test 
20 mice divided into groups of 10 mice each 
were used for this test. A group (test group) was 
administered the extract at a dose of 1500mg/kg 
for 30 days. The animals were bled on the 31
st
 
day  and serum  Alkaline  phosphatase, Alanine 
Transaminase, Aspatate Transaminase were 
assayed. PCV, creatinine, bilirubin levels were 
determined. 
 
Parasites Source and Animal Infection  
The parasites, Plasmodium berghei 
Keyberg174N strain were obtained from 
Nigerian Medical Research Institute (NIMR). 
Yaba- Lagos.1ml of blood from a donor mouse 
(at peak parasitemia) was diluted with 4ml of 
phosphate buffer. The acclimatized mice were 
infected (sterile technique employed) 
intraperitonally with 0.2ml of the diluted 
parasitised blood. Parasite density/µl of blood 
was estimated with the formula Parasites 
Count/WBC Count x 8000. 
 
Preparation of Extracts and Drugs for 
Bioassay 
The plant extract was given to the test animals 
after suspension in a mixture of distilled water 
and 0.5% sodium carboxymethyl cellulose 
(CMC). Chloroquine and Artesunate in 0.5% 
CMC were used as reference drugs (positive 
control). The untreated animals (negative 
control) were experimentally handled like the 
test animals except that they received 
appropriate volumes of the dosing vehicle. 
 
Suppressive Activity  
This was carried out using the method described 
by Datta
9
. Five groups of five mice each were 
infected with the P. berghei and 2 hours later 
were orally administered doses of 50 and 
100mg/kg of the extract, chloroquine 8mg/kg 
and Artesunate 120mg/kg per day for 4 days 
respectively. A group was left untreated but was 
given same volume of the dosing vehicle 
(CMC).  
 
Examination of the blood of each mouse for 
presence or absence of parasites started on the 
fifth day after the infection and administration of 
extracts and drugs. This continued every other 
day for 28 days or until death of animals.  
Therapeutic or Curative Activity 
Using the same method described by Datta
9
, five 
groups of five mice each were allowed to 
express 2% parasitemia after 5 days of infection, 
and were orally administered the extract at doses 
of 50 and 100mg/kg, chloroquine 8mg/kg and 
Artesunate 120mg/kg per day for 4 days.  A 
group was left untreated but was given same 
volume of the dosing vehicle (CMC). 
Examination of the blood of each mouse for 
presence or absence of parasites started on the 
ninth day after the infection and administration 
of extracts and drugs. This continued every other 
day for 28 days or until death of animals. 
Average percentage inhibition for suppressive 
and percent clearance rate for therapeutic 
activities for extract, chloroquine and artesunate 
treated mice were determined relative to the 
untreated mice (negative control). 
 
RESULTS 
 
Phytochemical analysis of methanolic root 
extract of R.longipedicellata showed that it 
consisted of alkaloids, cardiac glycosides of 
cardinolides group, anthraquinone glycosides, 
pheloba tannins, saponins and flavonoids. 
Percentage yield of crude drug was 17% while 
LD50 of the extract is 3650mg/kg, which gave a 
therapeutic index of 73 and 36.5 for 50mg and 
100mg/kg doses. The results from biochemical 
analysis of the serum of the mice after 
administration of extract are summarized in 
Table 1.  
 
Table 1: Biochemical analysis of blood after 
administration of   R. longipedicellata extract 
Parameters Control R. longipedicillata 
PCV% 36.50 ± 0.28 38.83 ± 0.16* 
ALP (UI/L) 37.23± 0.37 34.59 ± 0.50* 
SGOT 
(UI/L) 
14.43 ± 0.21 12.28 ± 0.02* 
SGPT (UI/L) 20.50 ± 0.84 15.64± 0.76* 
Creatinine 
(µmol/l) 
187.06 ± 1.15 162.30 ± 0.15* 
Total 
Biliribun 
(µmol/l) 
27.80 ± 0.23 26.46 ± 0.44 
* Significant 
 
The antiplasmodial activity of the plant extract 
for suppressive and therapeutic activities are 
summarised in Tables 2-4. 
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Table 2: Average percent parasitemia for untreated, extract and reference drugs 
treated mice over a 28-day period. 
Parasite density per microlitre of blood 
Treatment Dose 
mg/kg 
Chemo- 
 suppressive 
Chemotherapeutic 
Untreated -- 10729.94 ± 85 14162.5 ± 50 
R.longipedicellata 
Extract  
50 764.04 ± 68 7526.5 ± 50 
100 5927 ± 75 5447 ± 121 
Chloroquine treated  8 0 749.90 ± 91 
Artesunate treated 120 340 ± 75 2947.91 ± 81 
 
Table 3: Suppressive activity: percent inhibition, survival rate and survival period. 
Compounds Untreated CQ Artesunate R. longipedicellata 
Dose (mg/kg) - 8 120 50 100 
Clearance rate (%) 0 100 100 86.8 65.43 
Survival rate (%) 0 100 100 40 0 
Survial period 23 >28 > 28 >28 19 
 
Table 4: Chemotherapeutic: percent inhibition, survival rate and survival period 
Compounds Untreated CQ Artesunate R. longipedicellata 
Dose (mg/kg) - 8 120 50 100 
Clearance rate (%) 0 80.85 100 36.73 64.60 
Survival rate (%) 0 40 100 0 0 
Survival period 23 >28 > 28 22 25 
 
DISCUSSION  
 
This study was designed to establish the 
tolerance and antimalarial activity of methanolic 
root extract of R. longipedicellata, which would 
justify its use as a tonic and in the treatment of 
malaria by traditional medicine practioners. The 
high therapeutic indices of the extract point to a 
good safety margin for the plant extract. This 
substantiates the claim that herbal remedy might 
be safer than synthetic drugs
5,6
.  
 
Results Results  from  biochemical  analysis  of  
serum ALP, ALT, AST, Bilirubin and  
Creatinine that presented a significant decrease 
might mean that there was no cellular  injury  
causing  enzyme leakage  from the  liver into the 
bloodstream. This suggests that the extract might 
have hepatic effect without producing cellular 
necrosis. 
 
The observed increase in PCV (compared to 
control) coupled with the unchanged level of 
bilirubin is suggestive of a positive haemopoetic 
effect of R. longipedicellata, justifying its use as 
a tonic in folk medicine. The root extract of R. 
longipedicellata exhibited antiplasmodial 
activity comparable to that of conventional 
drugs (chloroquine and artesunate) presently in 
use for the treatment of malaria (Tables 2-4). 
Results of the suppressive activity (2hrs post-
infection) corroborate its use to prevent malaria 
in ethnomedicine. Its therapeutic use was also 
substantiated as it exhibited a good clearance 
rate (Table 4) at 100mg/kg (64.60%).  
 
The extract activity for both preventive and 
curative was quite comparable to those of the 
reference drugs – artesunate and chloroquine. 
The suppressive activity of the extract was not 
dose dependent; a higher dose corresponded to a 
higher parasitemia (Table 2) which confirms the 
variation in drug sensitivity profile of each life 
cycle stage of the plasmodium
10
. However, the 
chemotherapeutic activity was dose dependent, 
which means a higher dose, is required to clear 
the parasites from the blood stream once 
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infection has been established. Further efforts to 
isolate and characterize the active component in 
this plant extract are going on.  
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